Published in J Clin Invest on March 08, 2010
FGF-dependent regulation of VEGF receptor 2 expression in mice. J Clin Invest (2011) 1.56
The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis. Dev Cell (2013) 1.54
Think small: zebrafish as a model system of human pathology. J Biomed Biotechnol (2012) 1.30
Zebrafish as tools for drug discovery. Nat Rev Drug Discov (2015) 1.28
Endothelial ERK signaling controls lymphatic fate specification. J Clin Invest (2013) 1.24
Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells. J Exp Med (2014) 1.17
ETS factors regulate Vegf-dependent arterial specification. Dev Cell (2013) 1.16
The cytoplasmic domain of neuropilin 1 is dispensable for angiogenesis, but promotes the spatial separation of retinal arteries and veins. Development (2011) 1.15
Redox regulation of stem/progenitor cells and bone marrow niche. Free Radic Biol Med (2012) 1.15
VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart. EMBO Mol Med (2014) 1.08
Endothelial cell-dependent regulation of arteriogenesis. Circ Res (2013) 1.00
Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage. J Clin Invest (2015) 0.97
Mechanisms and regulation of endothelial VEGF receptor signalling. Nat Rev Mol Cell Biol (2016) 0.95
AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation. Angiogenesis (2014) 0.94
Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway. Blood (2011) 0.94
Endothelial RAF1/ERK activation regulates arterial morphogenesis. Blood (2013) 0.92
Molecular controls of arterial morphogenesis. Circ Res (2015) 0.91
Diverse functions for the semaphorin receptor PlexinD1 in development and disease. Dev Biol (2010) 0.91
Recent advances in vascular development. Curr Opin Hematol (2012) 0.90
Essential role of Apelin signaling during lymphatic development in zebrafish. Arterioscler Thromb Vasc Biol (2013) 0.88
Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome? Vascul Pharmacol (2012) 0.87
Coronary collateral growth--back to the future. J Mol Cell Cardiol (2011) 0.87
BAMBI regulates angiogenesis and endothelial homeostasis through modulation of alternative TGFβ signaling. PLoS One (2012) 0.85
CDP-diacylglycerol synthetase-controlled phosphoinositide availability limits VEGFA signaling and vascular morphogenesis. Blood (2012) 0.84
Vascular endothelial growth factor-A inhibits EphB4 and stimulates delta-like ligand 4 expression in adult endothelial cells. J Surg Res (2013) 0.84
Rapamycin antagonizes TNF induction of VCAM-1 on endothelial cells by inhibiting mTORC2. J Exp Med (2014) 0.84
BAMBI elimination enhances alternative TGF-β signaling and glomerular dysfunction in diabetic mice. Diabetes (2015) 0.82
Angiogenesis versus arteriogenesis: neuropilin 1 modulation of VEGF signaling. F1000Prime Rep (2015) 0.81
Combinatory action of VEGFR2 and MAP kinase pathways maintains endothelial-cell integrity. Cell Res (2011) 0.80
Protein Kinase D1 Signaling in Angiogenic Gene Expression and VEGF-Mediated Angiogenesis. Front Cell Dev Biol (2016) 0.80
Lymphatic fate determination: playing RAF with ERK. Cell Cycle (2013) 0.79
Globular adiponectin protects H9c2 cells from palmitate-induced apoptosis via Akt and ERK1/2 signaling pathways. Lipids Health Dis (2012) 0.79
AMIGO2, a novel membrane anchor of PDK1, controls cell survival and angiogenesis via Akt activation. J Cell Biol (2015) 0.79
Dual effects of VEGF-B on activating cardiomyocytes and cardiac stem cells to protect the heart against short- and long-term ischemia-reperfusion injury. J Transl Med (2016) 0.78
HIF2α Is an Essential Molecular Brake for Postprandial Hepatic Glucagon Response Independent of Insulin Signaling. Cell Metab (2016) 0.78
Lymphatic vessel abnormalities arising from disorders of Ras signal transduction. Trends Cardiovasc Med (2013) 0.78
Cellular context-mediated Akt dynamics regulates MAP kinase signaling thresholds during angiogenesis. Mol Biol Cell (2015) 0.77
LPA/PKD-1-FoxO1 Signaling Axis Mediates Endothelial Cell CD36 Transcriptional Repression and Proangiogenic and Proarteriogenic Reprogramming. Arterioscler Thromb Vasc Biol (2016) 0.76
p70 S6-kinase mediates the cooperation between Akt1 and Mek1 pathways in fibroblast-mediated extracellular matrix remodeling. Biochim Biophys Acta (2015) 0.76
Mechanisms of Amplified Arteriogenesis in Collateral Artery Segments Exposed to Reversed Flow Direction. Arterioscler Thromb Vasc Biol (2015) 0.76
Changing the Scale and Efficiency of Chemical Warfare Countermeasure Discovery Using the Zebrafish. Drug Discov Today Dis Models (2013) 0.75
Diet-induced obesity links to ER positive breast cancer progression via LPA/PKD-1-CD36 signaling-mediated microvascular remodeling. Oncotarget (2017) 0.75
Modulation of VEGF receptor 2 signaling by protein phosphatases. Pharmacol Res (2016) 0.75
Angiopoietin receptor Tie2 is required for vein specification and maintenance via regulating COUP-TFII. Elife (2016) 0.75
Stability and function of adult vasculature is sustained by Akt/Jagged1 signalling axis in endothelium. Nat Commun (2016) 0.75
The expanding role of neuropilin: regulation of transforming growth factor-β and platelet-derived growth factor signaling in the vasculature. Curr Opin Hematol (2016) 0.75
Insights into the Mechanisms Involved in Protective Effects of VEGF-B in Dopaminergic Neurons. Parkinsons Dis (2017) 0.75
Endothelial-Specific EphA4 Negatively Regulates Native Pial Collateral Formation and Re-Perfusion following Hindlimb Ischemia. PLoS One (2016) 0.75
VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol (2006) 12.09
In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol (2002) 11.62
Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. Nature (2008) 6.04
A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development (1998) 5.91
Phosphorylation and regulation of Raf by Akt (protein kinase B). Science (1999) 5.61
Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis. J Clin Invest (2005) 3.95
A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J (2001) 3.92
Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell (2002) 3.84
Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest (2002) 3.70
Angiogenic network formation in the developing vertebrate trunk. Development (2003) 3.66
Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat Med (2005) 3.60
Gridlock, a localized heritable vascular patterning defect in the zebrafish. Nat Med (1995) 3.59
Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol (2003) 3.51
Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol (1998) 3.27
Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration. Nature (2008) 3.19
gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science (2000) 2.90
Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet (2000) 2.65
phospholipase C gamma-1 is required downstream of vascular endothelial growth factor during arterial development. Genes Dev (2003) 2.62
Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res (2001) 2.55
Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease. J Am Coll Cardiol (2005) 2.42
The range of adaptation by collateral vessels after femoral artery occlusion. Circ Res (2006) 2.31
A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr Biol (1998) 2.20
Transcriptional control of endothelial cell development. Dev Cell (2009) 2.12
Angiogenesis: where do we stand now? Circulation (2005) 2.08
Cloning and characterization of neuropilin-1-interacting protein: a PSD-95/Dlg/ZO-1 domain-containing protein that interacts with the cytoplasmic domain of neuropilin-1. J Neurosci (1999) 2.03
Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell migration. J Cell Physiol (2000) 1.82
Selective regulation of arterial branching morphogenesis by synectin. Dev Cell (2006) 1.77
A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling. Functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein, GIPC. J Biol Chem (2001) 1.77
Artery/vein specification is governed by opposing phosphatidylinositol-3 kinase and MAP kinase/ERK signaling. Curr Biol (2006) 1.68
GIPC and GAIP form a complex with TrkA: a putative link between G protein and receptor tyrosine kinase pathways. Mol Biol Cell (2001) 1.65
The phosphoinositide 3-kinase/Akt pathway: a new target in human renal cell carcinoma therapy. Cancer Res (2006) 1.56
Shear stress activates p60src-Ras-MAPK signaling pathways in vascular endothelial cells. Arterioscler Thromb Vasc Biol (1998) 1.46
Vascular endothelial growth factor and semaphorin induce neuropilin-1 endocytosis via separate pathways. Circ Res (2008) 1.43
Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1. J Biol Chem (2008) 1.38
Suppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKCalpha in a Rac1 activation pathway. J Cell Biol (2009) 1.36
A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome. Arterioscler Thromb Vasc Biol (2007) 1.31
MAPping out arteries and veins. Sci STKE (2006) 1.26
MAPKs (ERK1/2, p38) and AKT can be phosphorylated by shear stress independently of platelet endothelial cell adhesion molecule-1 (CD31) in vascular endothelial cells. J Biol Chem (2005) 1.25
Delayed arteriogenesis in hypercholesterolemic mice. Circulation (2005) 1.19
High-resolution quantitative computed tomography demonstrating selective enhancement of medium-size collaterals by placental growth factor-1 in the mouse ischemic hindlimb. Circulation (2006) 1.13
Role of human cripto-1 in tumor angiogenesis. J Natl Cancer Inst (2005) 1.10
The antiangiogenic activity of rPAI-1(23) inhibits vasa vasorum and growth of atherosclerotic plaque. Circ Res (2009) 1.07
Synectin/syndecan-4 regulate coronary arteriolar growth during development. Dev Dyn (2007) 1.00
Arteriogenesis: a focus on signal transduction cascades and transcription factors. Thromb Haemost (2007) 0.97
Inhibition of the cardiac angiogenic response to exogenous vascular endothelial growth factor. Surgery (2004) 0.93
Synectin-dependent gene expression in endothelial cells. Physiol Genomics (2006) 0.92
Effects of coronary artery disease on expression and microvascular response to VEGF. Am J Physiol (1998) 0.83
Synectin-dependent regulation of arterial maturation. Dev Dyn (2009) 0.82
Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol (2013) 21.32
Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA). Nat Methods (2010) 8.86
Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol (2007) 8.08
Targeted gene disruption in somatic zebrafish cells using engineered TALENs. Nat Biotechnol (2011) 7.05
Rapid mutation of endogenous zebrafish genes using zinc finger nucleases made by Oligomerized Pool ENgineering (OPEN). PLoS One (2009) 6.67
In vivo drug discovery in the zebrafish. Nat Rev Drug Discov (2005) 6.56
Tissue-engineered lungs for in vivo implantation. Science (2010) 5.90
BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med (2008) 4.20
Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med (2007) 4.11
Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature (2010) 3.70
Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat Med (2005) 3.60
Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science (2010) 3.60
Highly efficient generation of heritable zebrafish gene mutations using homo- and heterodimeric TALENs. Nucleic Acids Res (2012) 3.41
Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat Chem Biol (2010) 2.87
Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation (2008) 2.82
Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis. Circ Res (2007) 2.74
Heritable and precise zebrafish genome editing using a CRISPR-Cas system. PLoS One (2013) 2.74
Targeted mutagenesis in zebrafish using customized zinc-finger nucleases. Nat Protoc (2009) 2.67
Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat Biotechnol (2004) 2.57
Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. Bioorg Med Chem Lett (2008) 2.51
Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature (2011) 2.47
Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation (2011) 2.45
Syndecans: new kids on the signaling block. Circ Res (2005) 2.43
Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization. Cell (2011) 2.42
Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation (2003) 2.42
VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis. Dev Cell (2010) 2.37
A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat Med (2009) 2.31
Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice. Blood (2004) 2.23
Akt1 in endothelial cell and angiogenesis. Cell Cycle (2006) 2.22
ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway. Dev Cell (2012) 2.14
Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation (2005) 2.13
The FGF system has a key role in regulating vascular integrity. J Clin Invest (2008) 2.09
Notch1b and neuregulin are required for specification of central cardiac conduction tissue. Development (2006) 2.00
Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells. PLoS One (2008) 1.99
Integrin signaling is critical for pathological angiogenesis. J Exp Med (2006) 1.91
Medical device development: from prototype to regulatory approval. Circulation (2004) 1.90
VEGF-integrin interplay controls tumor growth and vascularization. Proc Natl Acad Sci U S A (2005) 1.84
Selective regulation of arterial branching morphogenesis by synectin. Dev Cell (2006) 1.77
Branching morphogenesis. Circ Res (2008) 1.77
Angiogenesis-dependent and independent phases of intimal hyperplasia. Circulation (2004) 1.71
Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression. J Natl Cancer Inst (2013) 1.69
Artery/vein specification is governed by opposing phosphatidylinositol-3 kinase and MAP kinase/ERK signaling. Curr Biol (2006) 1.68
FGF regulates TGF-β signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression. Cell Rep (2012) 1.63
Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. Blood (2011) 1.61
A novel role for platelet secretion in angiogenesis: mediating bone marrow-derived cell mobilization and homing. Blood (2011) 1.61
Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation. Nat Chem Biol (2009) 1.58
Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis. Angiogenesis (2009) 1.58
Fibroblast growth factor regulation of neovascularization. Curr Opin Hematol (2008) 1.56
FGF-dependent regulation of VEGF receptor 2 expression in mice. J Clin Invest (2011) 1.56
Evidence Combination From an Evolutionary Game Theory Perspective. IEEE Trans Cybern (2015) 1.54
The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis. Dev Cell (2013) 1.54
Zebrafish-based small molecule discovery. Chem Biol (2003) 1.53
Evaluating sensor reliability in classification problems based on evidence theory. IEEE Trans Syst Man Cybern B Cybern (2006) 1.53
Akt1 signaling regulates integrin activation, matrix recognition, and fibronectin assembly. J Biol Chem (2007) 1.52
Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice. Blood (2011) 1.49
Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice. J Clin Invest (2007) 1.49
Post-market approval surveillance: a call for a more integrated and comprehensive approach. Circulation (2004) 1.49
Kindlins in FERM adhesion. Blood (2010) 1.48
Molecular pathway for cancer metastasis to bone. J Biol Chem (2003) 1.47
VEGF signaling inside vascular endothelial cells and beyond. Curr Opin Cell Biol (2012) 1.44
AML1-ETO reprograms hematopoietic cell fate by downregulating scl expression. Development (2008) 1.44
Vascular endothelial growth factor and semaphorin induce neuropilin-1 endocytosis via separate pathways. Circ Res (2008) 1.43
Clustering induces redistribution of syndecan-4 core protein into raft membrane domains. J Biol Chem (2002) 1.43
Growth differentiation factor 9:bone morphogenetic protein 15 heterodimers are potent regulators of ovarian functions. Proc Natl Acad Sci U S A (2013) 1.42
Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization. Circulation (2009) 1.41
Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1. J Biol Chem (2008) 1.38
Chemical informatics and target identification in a zebrafish phenotypic screen. Nat Chem Biol (2011) 1.37
Syndecan-4 regulates subcellular localization of mTOR Complex2 and Akt activation in a PKCalpha-dependent manner in endothelial cells. Mol Cell (2008) 1.36
Suppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKCalpha in a Rac1 activation pathway. J Cell Biol (2009) 1.36
Unraveling tissue regeneration pathways using chemical genetics. J Biol Chem (2007) 1.35
Thrombospondin-1 up-regulates expression of cell adhesion molecules and promotes monocyte binding to endothelium. FASEB J (2005) 1.34
Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse. Proc Natl Acad Sci U S A (2003) 1.33
Syndecan-4 clustering induces cell migration in a PDZ-dependent manner. Circ Res (2006) 1.31
Integrin and growth factor receptor alliance in angiogenesis. Cell Biochem Biophys (2008) 1.31
Angiogenesis in melanoma. Semin Oncol (2007) 1.30
Fibroblast growth factor 2 endocytosis in endothelial cells proceed via syndecan-4-dependent activation of Rac1 and a Cdc42-dependent macropinocytic pathway. J Cell Sci (2004) 1.30
Identification of a novel retinoid by small molecule screening with zebrafish embryos. PLoS One (2008) 1.30
Regulation of protein kinase B/Akt activity and Ser473 phosphorylation by protein kinase Calpha in endothelial cells. Cell Signal (2004) 1.29
Fibroblast growth factor-specific modulation of cellular response by syndecan-4. J Cell Biol (2002) 1.26
Translational physiology: porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis. J Appl Physiol (1985) (2003) 1.25
The extracellular matrix and blood vessel formation: not just a scaffold. J Cell Mol Med (2007) 1.25
Endothelial ERK signaling controls lymphatic fate specification. J Clin Invest (2013) 1.24
Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis. Circ Res (2012) 1.24
Non-canonical fibroblast growth factor signalling in angiogenesis. Cardiovasc Res (2007) 1.22
PKCalpha activates eNOS and increases arterial blood flow in vivo. Circ Res (2005) 1.22